Author

Laura Mercolini

University of BolognaORCID 0000-0002-0644-9461Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

André Q. FigueiredoiD· 1 shared Carlos LodeiroiD· 1 shared Dimitrios K. KorentzelosiD· 1 shared Gianluca MoronciniiD· 1 shared Hélder MansinhoiD· 1 shared Hugo Miguel SantosiD· 1 shared Inês F. DomingosiD· 1 shared Jacek R. WiśniewskiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

André Q. FigueiredoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Absolute quantitative proteomics guides patient-stratified drug repurposing in clear cell and papillary renal cell carcinoma.

André Q. Figueiredo, Inês F. Domingos, Carlos Lodeiro, Rajiv Dhir, Luís B. Carvalho, Laura Mercolini, Jacek R. Wiśniewski, Gianluca Moroncini, Mariana Silva Medeiros, Luís Campos Pinheiro, Hélder Mansinho, Hugo Miguel Santos, Dimitrios K. Korentzelos, José Luís Capelo

This paper uses absolute quantitative proteomics to identify patient-specific drug repurposing strategies for clear cell and papillary renal cell carcinoma.

bioRxiv · Jul 17, 2026 · PreprintBiochemistry